Worse allergy seasons. A hotter climate means earlier blooms in spring and a longer season for fall allergens such as ragweed and mugwort. Basically, more warmth means more plants and more pollen, according to the review
Source link: http://www.webmd.com/allergies/news/20080805/global-warming-may-up-allergies-asthma
These discussions encompass once- and twice daily LABAs (long-acting beta agonists), steroids, leukotriene inhibitors, anticholinergics, FLAP, CXCR2 and other mechanisms. The panel also considers each of these approaches in the context of prn vs. maintenance dosing.
There is a lot of commercial development activity aimed at identifying biologicals that have disease-modifying activity, both in asthma and COPD, said
Jeff Berk, the report's author. Our panel sorts through the biologicals in the pipeline, including monoclonals targeting IL-5, IL-9 and IL-13/IL-4, and picks their favorites. Also addressed in this report:
-- What are the key unmet needs in asthma and in COPD, and which compounds/combinations are best poised to fill the need gaps? -- Which of the new biologicals in development show the most promise, and why? Will these be likely to replace current standard of care? -- Will developers be able to show disease-modification benefits in COPD? -- How will the increased mortality seen in the SMART trial affect usage of LABAs in asthma? Companies/Partnerships discussed include: Aerovance (Bayer-Schering), Altair Therapeutics/Isis, Amgen/
Takeda Bio, Boehringer Ingelheim, Ception, Chiesi, Cornerstone BioPharma/Critical Therapeutics/Dey, Forest, GlaxoSmithKline, GSK/Theravance, GSK/Amira, Merck, Merck/Schering- Plough, Novartis, Novartis/Genentech, Novartis/Schering-Plough/SkyePharma, Nycomed/Sepracor, Schering-Plough/ALK-Abello, Sepracor, SkyePharma/Kos/Abbott, Stallergenes/Paladin, Wyeth.
This report can be purchased by contacting MedPredict.
About MedPredict
MedPredict (http://www.medpredict.com) maintains a proprietary database of over 1,000 global physician thought leaders, including 40+ specialties in 30+ therapeutic categories. Based on primary interviews with these thought leaders, MedPredict publishes periodic reports in each category to keep clients up-to-date on emerging trends and competitive activity. The reports include thought leader reactions to recent publications and medical conferences, as well as clinical, regulatory and marketing activity.
SOURCE MedPredict
Source link: http://www.earthtimes.org/articles/show/global-pulmonology-thought-leaders-provide,494651.shtml
Related:
Fortwo crash test
Sugar based fuel
875 16.5 tires
Refrigerator seal fix
7 stuffed horse
Umbrella take that
Super devil juice
Dog chain fence
Electric fence poles
Prefab teller station
No comments:
Post a Comment